US Stock MarketDetailed Quotes

AIMT Aimmune Therapeutics

Watchlist
  • 0.000
  • 0.0000.00%
Close Jul 26 09:30 ET
0Market Cap0.00P/E (TTM)

About Aimmune Therapeutics Company

Aimmune Therapeutics Inc is a company operating in the United States biotechnology industry. Its main focus is in the development of product candidates to combat peanut and other food allergies. The company's therapeutic approach, which is referred to as Characterized Oral Desensitization Immunotherapy, is a system designed to desensitize patients to food allergens using characterized biologic products, defined treatment protocols, and support services.

Company Profile

SymbolAIMT
Company NameAimmune Therapeutics
Issue Price16.00
CEODr. Jayson Donald Alexander Dallas
MarketNASDAQ
Employees275
Securities TypeOrdinary Shares
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jayson Donald Alexander Dallas
  • Director, President and Chief Executive Officer
  • --
  • Eric H. Bjerkholt
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Daniel C. Adelman, M.D.
  • Chief Medical Officer
  • --
  • Andrew Oxtoby
  • Chief Commercial Officer
  • --
  • Mark D. Mcdade
  • Chairman of the Board
  • --
  • Gregory Behar
  • Independent Director
  • --
  • Patrick G. Enright
  • Independent Director
  • --
  • Dr. Brett K. Haumann
  • Independent Director
  • --
  • Mark T. Iwicki
  • Independent Director
  • --
  • Stacey D. Seltzer
  • Independent Director
  • --
  • Kathryn E. Falberg
  • Independent Director
  • --
  • Douglas T. Sheehy
  • General Counsel and Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg